MedPath

Effects of Ramadan fasting on cholesterol-metabolizing protein PCSK9 in people with obesity

Not Applicable
Completed
Conditions
Prevention of elevated cholesterol by lowering circulating PCSK9 in metabolically healthy people with obesity
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN87587044
Lead Sponsor
niversity of Sharjah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Metabolically healthy male or female adult subject (>18 years)
2. Overweight/obesity (body mass index (BMI) >25 kg/m²)
3. Willing to fast for consecutive four weeks from dawn to sunset, and willing to participate and sign the informed consent

Exclusion Criteria

1. History of metabolic syndrome, diabetes, or cardiovascular disease
2. Taking regular medications or supplements
3. Following a weight-reducing diet
4. History of bariatric surgery within the last 6-9 months before commencing intermittent fasting
5. Pregnant or peri-menopausal woman

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath